Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 31Terminated 12Recruiting 10Active not recruiting 4Withdrawn 2Unknown 2No longer available 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 159Gastrointestinal 19Gynecologic 16Genitourinary 14Breast 14Head & Neck 13Lymphoid 12CNS 12Thoracic 8Dermatologic 5Other hematologic neoplasm 4Myeloid 3Endocrine 3Other solid neoplasm 2Other 2NET 2Plasma cell 1Classical hematology 1

Conditions

Solid Tumor 87Advanced Solid Tumor 77Advanced Solid Tumors 70Mesothelioma, Malignant 40Mesothelioma 27Solid Tumor, Adult 26Solid Tumors 24Unspecified Adult Solid Tumor, Protocol Specific 21Retinoblastoma 19Carcinoma, Non-Small-Cell Lung 11Stomach Neoplasms 9Ovarian Neoplasms 8Advanced Malignant Solid Tumors 7Advanced Malignant Solid Tumor 7Pancreatic Neoplasms 6Melanoma 6Colorectal Neoplasms 6Carcinoma, Renal Cell 6Lung Neoplasms 5Esophageal Neoplasms 5Endometrial Neoplasms 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Pleural Effusion, Malignant 4Malignant Solid Tumors 4Lymphoma 4Locally Advanced or Metastatic Solid Tumors 4Carcinoma, Hepatocellular 4Unspecified Childhood Solid Tumor, Protocol Specific 3

Interventions

regorafenib 1Clinical Trials, Phase II as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Sarcoma × Other solid neoplasm × Clear all
NCT03475953 2023-03-03

REGOMUNE

Institut Bergonié

Phase 1/2 Unknown
747 enrolled
BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

NCT05415098 2022-11-16

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

Ascentage Pharma Group Inc.

Phase 1 Unknown
90 enrolled
GastrointestinalHead & NeckLymphoidOther solid neoplasmSarcomaThoracic

Nasopharyngeal Carcinoma, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Stomach Neoplasms, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡